Klin Onkol 2002; 15(3): 111-114.
Summary: Supportive care in cancer patients is an important treatment modality, as diferent complications can limit the benefit of antineoplastic therapy. In recent years some new drugs has been introduced into clinical practice. Brief descriptions of new antivirals, antibacterials and antimycotics are given. Progress has been made also in the control of chemotherapy-induced emesis (NK receptor antagonists) and therapy of hyperuricemia (urate oxidase). For cancer-related pain can be used, in addition to the standard treatment, bispohosphonates and novel sublingual fentanyl citrate (Actiq). .
